Close
Oct 16, 2026
- Reported revenue
- $34.47 bn Q2 2026
- Annual revenue growth
- 17.4% Q2 2026
- Operating margin
- 21.3% Q2 2026
- Reported P/E
- 14.58× 2026-10-14
1.Share price
Daily closes, adjusted for stock splits. Price return excludes dividends. Hover or tap to explore.
2.Company news
View allMorgan Stanley’s June results show earnings strength, not its full source
A wealth-led financial franchise reported better margins, while negative bank cash movements call for context rather than a simple cash alarm.
3.Our verdict
Waiting for a better price
The published targets do not meet our required upside.
Analyst price targets · 12 months
Published analyst targets, compared with our dated share price.
- Average target
- $213.27
- Price potential
- +18.1%
- Analysts
- 25
- Low–high range
- $185.00$262.00
- Historical SPY reference · 5 years
- +11.1%
- Average target versus SPY hurdle
- 7 pp
- Buy threshold below
- $179.79
Why now
- The company delivers the operating progress reflected in analyst expectations.
What would change our view
- Analyst targets or the reported financial position deteriorate.
4.Investment case at publication
Morgan Stanley’s wealth franchise anchors a powerful markets business
The June fiscal quarter brought stronger reported profitability, but banking cash movements require a different reading from the earnings statement.
Morgan Stanley’s business strength lies in combining client wealth management with institutional financial services. The reported June fiscal quarter supports that assessment through higher revenue, operating margin and diluted earnings against the same fiscal quarter of the prior year, without establishing which franchise drove the gains.
Wealth and asset management provide a substantial income base alongside investment banking and institutional trading.
Reported revenue, operating margin and diluted earnings improved against the same fiscal quarter of the prior year.
Negative operating cash flow needs a banking-specific interpretation; the available figures do not establish financial distress or distributable cash.
5.Latest quarter
Morgan Stanley’s June fiscal quarter showed a more profitable consolidated business than the same fiscal quarter of the prior year. Reported revenue rose, operating margin widened and diluted earnings per share increased.
These results establish stronger reported performance, but not its source. The available statements do not separate the contribution from wealth management, investment banking or institutional trading.
| Metric | Period | Value |
|---|---|---|
| Reported revenue | Q2 2026 | $34.47 bn |
| Annual revenue growth | Q2 2026 | 17.4% |
| Reported operating income | Q2 2026 | $7.35 bn |
| Operating margin | Q2 2026 | 21.3% |
| Profit per share, after dilution | Q2 2026 | $3.46 |
6.The business
Morgan Stanley manages client wealth and provides investment banking and trading services.
We like the breadth of this franchise. Morgan Stanley pairs the everyday work of managing client money with a formidable presence in institutional finance. Its strongest opportunity is to make that combination more valuable to clients, drawing on a substantial wealth platform rather than relying solely on deal activity.
It is also a bank holding company. Customer deposits predominantly originate from cash swept out of wealth management and brokerage accounts, tying its banking funding base closely to its client businesses.
7.Growth
Reported consolidated revenue in the June fiscal quarter exceeded the same fiscal quarter of the prior year. It also exceeded the preceding fiscal quarter, showing that the revenue expansion was not limited to the annual comparison.
The company earns income through managing assets, serving brokerage clients, advising on transactions and facilitating institutional trading. These activities respond to different client needs, but the available figures do not identify their individual growth contributions. Reported total revenue should not be treated as net interest income or an issuer-defined net revenue measure.
Revenue history
$ bnConsolidated reported quarterly revenue; compare the same fiscal quarter across years.
View chart data
| Period | Revenue ($ bn) |
|---|---|
| Q3 2023 | $23.42 |
| Q4 2023 | $23.83 |
| Q1 2024 | $26.27 |
| Q2 2024 | $26.48 |
| Q3 2024 | $27.37 |
| Q4 2024 | $27.16 |
| Q1 2025 | $29.13 |
| Q2 2025 | $29.35 |
| Q3 2025 | $31.19 |
| Q4 2025 | $29.99 |
| Q1 2026 | $33.15 |
| Q2 2026 | $34.47 |
8.Profitability
Operating margin measures the share of reported revenue left as reported operating income. In the June fiscal quarter, that share was higher than in the same fiscal quarter of the prior year and slightly higher than in the preceding fiscal quarter.
The result shows that operating income grew faster than revenue against the same fiscal quarter of the prior year. It does not establish whether the improvement came from spending discipline, business mix or other factors, because the necessary expense and segment detail is unavailable.
Operating margin
%Reported consolidated operating income divided by revenue. Missing provider fields remain unavailable.
View chart data
| Period | Operating margin (%) |
|---|---|
| Q3 2023 | 13.43 |
| Q4 2023 | 8.8 |
| Q1 2024 | 16.73 |
| Q2 2024 | 15.38 |
| Q3 2024 | 15.42 |
| Q4 2024 | 18.06 |
| Q1 2025 | 19.03 |
| Q2 2025 | 15.75 |
| Q3 2025 | 19.33 |
| Q4 2025 | 19.21 |
| Q1 2026 | 21.15 |
| Q2 2026 | 21.32 |
9.Earnings
Reported diluted earnings per share increased against both the same fiscal quarter of the prior year and the preceding fiscal quarter. This measure spreads earnings attributable to shareholders across the diluted weighted-average share base.
The available consolidated net income and share figures should retain their reported definitions. They do not establish a buyback contribution to earnings growth, and no adjusted earnings reconciliation is available.
| Metric | Period | Value |
|---|---|---|
| Other non-operating income | Q2 2026 | $0 bn |
| Reported consolidated net income | Q2 2026 | $5.65 bn |
| Average shares, including potential dilution | Q2 2026 | 1.57 bn shares |
Reported diluted EPS
$The published provider EPS field. No ADR, currency or adjusted-earnings conversion is inferred.
View chart data
| Period | Diluted EPS ($) |
|---|---|
| Q3 2023 | $1.38 |
| Q4 2023 | $0.85 |
| Q1 2024 | $2.02 |
| Q2 2024 | $1.82 |
| Q3 2024 | $1.88 |
| Q4 2024 | $2.22 |
| Q1 2025 | $2.6 |
| Q2 2025 | $2.13 |
| Q3 2025 | $2.8 |
| Q4 2025 | $2.68 |
| Q1 2026 | $3.43 |
| Q2 2026 | $3.46 |
10.Cash flow
For the reported June fiscal quarter, operating cash flow was negative, whereas it was positive in the same fiscal quarter of the prior year. Gross cash purchases of property, plant and equipment were higher than in that prior-year quarter. The available detail does not identify what those purchases funded.
For the trailing twelve months ended at the June quarter-end, operating cash flow was also negative. Operating cash flow less gross cash purchases of property, plant and equipment was negative for both that trailing period and the reported quarter.
Bank cash-flow statements include movements associated with deposits and lending, so a negative figure alone does not establish distress. The derived cash-after-purchases measure excludes asset sales, intangible investment, leases and noncash commitments; it is neither issuer-defined free cash flow nor distributable bank earnings.
| Metric | Period | Value |
|---|---|---|
| Cash generated by operations | TTM 2026-06-30 | -$15.59 bn |
| Cash after investments | TTM 2026-06-30 | -$18.58 bn |
| Cash generated by operations | Q2 2026 | -$2.75 bn |
| Building and equipment investments | Q2 2026 | $0.82 bn |
| Cash after investments | Q2 2026 | -$3.57 bn |
Cash generated versus cash invested
$ bnMassive reported quarterly operating cash flow less gross cash PPE purchases, calculated in code. PPE sales, intangible investments, leases and noncash commitments are excluded. This is separate from a broader issuer-defined productive-assets cash measure. Missing fields remain unavailable.
View chart data
| Period | Operating cash flow ($ bn) | Gross cash PPE purchases ($ bn) | OCF less gross PPE purchases ($ bn) |
|---|---|---|---|
| Q3 2024 | -$17.32 | $0.92 | -$18.24 |
| Q4 2024 | $11.8 | $0.88 | $10.92 |
| Q1 2025 | -$23.98 | $0.71 | -$24.69 |
| Q2 2025 | $11.83 | $0.76 | $11.07 |
| Q3 2025 | -$3.33 | $0.71 | -$4.05 |
| Q4 2025 | -$2.41 | $0.71 | -$3.12 |
| Q1 2026 | -$7.1 | $0.75 | -$7.85 |
| Q2 2026 | -$2.75 | $0.82 | -$3.57 |
11.Balance sheet
Morgan Stanley reports substantial cash, short-term investments and noncurrent debt and capital lease obligations at the June quarter-end. Customer deposits also form part of its banking funding model, rather than representing ordinary industrial-company borrowing.
Short-term investments should not automatically be treated as cash available to repay debt. The reported categories do not show asset encumbrance, regulatory capital strength or the full funding maturity profile. Market exposure and the need to maintain dependable funding are material risks for this business.
| Metric | Period | Value |
|---|---|---|
| Cash and readily available funds | 2026-06-30 | $160.14 bn |
| Short-term investments | 2026-06-30 | $1,008.31 bn |
| Short-term debt | 2026-06-30 | $0 bn |
| Long-term debt and leases | 2026-06-30 | $443.11 bn |
12.Valuation
The current analyst targets and SPY comparison are shown in Our verdict.
View the current assessment13.What we are watching
The next useful evidence is a clearer account of which businesses generated the revenue and margin gains. Wealth client assets, client cash balances and institutional activity would help distinguish the durability of the income base from market-sensitive performance.
Funding disclosures and regulatory capital measures also deserve attention. They would add meaning to the reported balance sheet and help explain negative operating cash movements without confusing them with an earnings shortfall.